Becton, Dickinson Receiving $24 Million Federal Investment to Ramp Up Coronavirus Test Kit Manufacturing

Becton, Dickinson Receiving $24 Million Federal Investment to Ramp Up Coronavirus Test Kit Manufacturing

Becton, Dickinson (NYSE: BDX) is about to increase production of its SARS-CoV-2 diagnostic solution thanks to the largesse of two arms of the federal government. The healthcare equipment specialist announced Thursday that the Department of Defense (DOD), supported by the Department of Health and Human Services (HHS), is providing it with a $24 million investment for the purpose. The money will be devoted to the production of Becton, Dickinson’s Veritor System for Rapid Detection of SARS-CoV-2, a test that the company says can produce results within 15 minutes of being administered.


More:  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Southwest Airlines, Tupperware Brands Corporation, Becton, Dickinson and Company, and Aaron’s and Encourages Investors to Contact the Firm

More from: | Category: Medical Device Company News